From: RLS-0071, a dual-targeting anti-inflammatory peptide - biomarker findings from a first in human clinical trial
Cohort
Number of subjects (N)
C1q (mcg/ml) median change (± SD)
P-value
placebo
8
-2 (± 12)
NS
2 mg/kg
6
-2 (± 7)
10 mg/kg
0 (± 8)
40 mg/kg
+ 5 (± 11)
120 mg/kg
+ 18 (± 7)
0.004